ERBB2 and breast cancer: In terms of the expression of biomarkers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), breast cancer can be divided into the luminal A, luminal B, HER-2 overexpression, and triple-negative breast cancer (TNBC) types [2].